News. It's what's up.

FDAecigs.jpg
REVISED FDA BLOOD BLOOD GUIDANCE ENDS TRAVEL DEFERRAL RECOMMENDATIONS FOR vCJD RISK

May 23, 2022

The FDA has issued revised Blood Guidance regarding CJD & vCJD. The revised guidance no longer recommends deferral of blood donors for travel to the U.K., France, or Ireland and/or receipt of a blood transfusion in any of these countries. Deferral recommendations for other medical history risk factors remain, but all geographic risk evaluation recommendations have been lifted.

 

Here is a link to the guidance document:  https://www.fda.gov/media/124156/download

 

These changes are limited in scope to blood donation. Donor screening requirements for tissue donors still remain unchanged. The Blood Donor editions of the Donor Screening GEO Guide will need to be revised to remove the vCJD section at some point in the future, but this is not an urgent change.

AdobeStock_253924319 (3).jpeg
2022 UPDATE SUBSCRIPTION PRICING RELEASED

February 16, 2022

Donor Screening GEO Guide subscription pricing for the 2022 term (from April 1, 2022 through March 31, 2023) has been determined. COVID-19 update subscriptions will not be offered for the 2022 term.

​Subscription pricing remains the same as for 2021 and 2020.

 

Update projections for 2022 included consideration of the following factors:

  • Possible changes in malaria-endemic areas in 13 countries, potentially affecting 25 maps (with an estimated 12 overlays impacted) based on analysis of the 2021 WHO World Malaria Report.

  • Anticipated publication of the 2023 edition of the CDC's Yellow Book in the Fall of 2022.

  • Possible publication of revised FDA tissue guidance on vCJD, to harmonize donor screening recommendations with the revised recommendations for blood donors issued in April 2020.

  • Possible triggering of donor screening for Ebola Virus Disease in 2022 based on ongoing sporadic cases in DR Congo and Guinea.

AdobeStock_388399619.jpeg
DONOR SCREENING GEO GUIDE UPDATED:
CDC YELLOW BOOK MALARIA REVISIONS,
COVID-19, HIV-1 GROUP O, & LEISHMANIASIS SECTIONS RETIRED

January 17, 2022

An update to the Donor Screening GEO Guide has been issued in response to the CDC’s revised malaria information published in the online version of the 2020 CDC Yellow Book on December 13, 2021. This update also includes updated malaria maps for several countries based on routine review of relevant information such as location, population, elevation, and/or resort information. This update marks the expansion of scope of the malaria Ports of Call list to cover tourist ports worldwide. Additionally, COVID-19, HIV-1 Group O, and Leishmaniasis information has been retired from the Donor Screening GEO Guide.

 

Highlights of this update include:

  • ​Revision of the Donor Screening GEO Matrix.

  • Introduction of the new, expanded list of Malaria-Endemic Tourist Ports of Call Worldwide.

  • Addition of three new malaria detail maps for the Brazilian states of Espírito Santo, Goiás, and Minas Gerais; Rio de Janeiro; and São Paulo.

  • Revision of malaria maps of Afghanistan, Afghanistan: Kabul Region, Bangladesh, Bolivia, Botswana, Brazil, Colombia, Colombia Highlands, Costa Rica, Dominican Republic, Ecuador, Ethiopia, French Guiana, Guatemala, India, Indonesia, Indonesia: Bali, Indonesia: Java, Indonesia: Nusa Tenggara Region, Malaysia, Malaysia: Kuala Lumpur, Malaysia: Penang State, Namibia, Nepal, Nicaragua, Panama, Peru, South Africa, South Korea, South Korea: Inch’ŏn, Kangwŏn, and Kyŏnggi Provinces, Suriname, Tanzania, Thailand, Thailand: Southern Region; Vietnam, Vietnam: Mekong Delta, and Vietnam: Red River Delta.

  • Addition of new malaria map overlays for Bangladesh, French Guiana, and Guatemala. (Reference Editions only)

  • ​Retirement of the malaria maps of Guatemala City (Guatemala), Lake Atitlan (Guatemala), Iran and Timor-Leste.

  • Revision of malaria reference lists and malaria section table of contents.

  • Revision of malaria Technical Notes and malaria map overlays for revised malaria maps (Reference Editions only)

  • Revision of vCJD section Screening Facts and Technical Notes (Blood Donor Editions only)

  • Retirement of the Leishmaniasis, HIV-1 Group O, and COVID-19 sections.